Active ad and exact outbound link observed in Meta Ad Library on October 22, 2026. The page image and section source are the existing October 20 capture of this destination. Offers and product selections may change. Selection reflects creative and page structure; performance is not available.

Co-founder's oral GLP-1 · news-style headline. The creator’s opening promise continues into an editorial introduction, repeated purchase options, customer stories, and FAQs. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The headline does two jobs at once: it says who's behind the product (a co-founder) and what it's for (a needle-free alternative), in the shape of a news story. The article frame, with a share button and portrait, makes it feel like coverage rather than a promotion, which earns a look from people who skip product shots. Like its sister ad about looking into Ozempic, it lands on an advertorial, so the editorial feel carries through the click. The brand ran several versions of this creative.
The ad leans on the co-founder without saying who she is or why her name should matter, so viewers who don't recognize her get a generic article. The copy beneath is the same broad line used in the brand's other needle-free ads and adds nothing to the headline. If you make one like this with a known founder, name her in the copy and give one reason she started the company; if your founder isn't known, the story angle (what she was looking for and what she found) will carry more than the title.
The editorial frame borrows the trust of a news story.
It ties the product to a real person and positions it against a well-known option in one line.
It names the product so the click leads somewhere specific.
It sends people to the needle-free GLP-1 advertorial, a focused editorial page and a natural follow-on for a news-style ad. The hero, Skip the shot, claims WLP-1 raises the body's own GLP-1 by up to 321%, and Five reasons why people are choosing the injection-free route covers cost and prescriptions, absorption, three pathways, side effects and the two-capsule routine. What customers report, the product block, FAQs and a refund promise follow. The page doesn't feature the co-founder in its captured sections, so the person the ad leads with disappears after the click; a short founder note near the top would keep the thread. It's one of 10 ads in the Fluid library pointing here.
An advertorial for WLP-1 that frames the product as a needle-free route, with a co-founder byline, three benefit tiles, an early plan box, five numbered reasons, customer reports, FAQs and a refund guarantee. 10 Absorption Company ads in the Fluid library link here, mainly editorial-style statics and creator videos about no needles and no prescription.
States the GLP-1 claim, the no-needle framing and the price-from line with a study disclaimer, answering what this is and why read on.
Opens in the co-founders' voice with the brand's case against injections, answering who is talking and what problem they see.
Names fullness, quieter cravings and burning more at rest, answering what the product is claimed to do.
Offers 3-month, 6-month and monthly plans with badges and the guarantee, answering how to buy right away.
Numbered sections on cost, absorption, three pathways, side effects and the routine, answering the main objections one at a time.
Shares what customers report, answering whether people like the reader have tried it.
Restates WLP-1 with its plans, answering how to order after reading.
Covers remaining questions, answering the last doubts before purchase.
Promises a refund if it doesn't work, with free shipping and cancel-anytime tiles, answering what happens if it doesn't suit you.
Read the full breakdown of this page
One of 188 The Absorption Company ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.